Prescription digital therapeutics are emerging as an entirely new therapeutic modality. Corey McCann, President and CEO of Pear Therapeutics, chats with me about what they are, how they evolve as more data are collected, and the subsequent changes that are made to the treatment paradigms of neurological and psychological disorders. We also discuss what it took to get FDA approval for "software as a therapy," what skills are essential to succeeding in the space, and the growing presence of remote and asynchronous care.

Check out the glossary of terms, definitions, and resources (and get a sneak peak of the future conversations lined up!) here: bit.ly/datapulse-glossary